Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles

Japanese Journal of Ophthalmology

Volumn 44, Issue 2, 2000, Pages 106-109

  Ishikawa, Hitoshi ^a   Mitsui, Yoshihisa ^a   Yoshitomi, Takeshi ^a   Mashimo, Kimiyo ^a   Aoki, Shigeru ^b   Mukuno, Kazuo ^b   Shimizu, Kimiya ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Albino rabbit; Botulinum toxin type A; Electrical field stimulation; Pigmented rabbit; Substance P

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN A; CARBACHOL; MELANIN; SUBSTANCE P; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ALBINISM; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; MUSCLE TWITCH; NERVE ENDING; NONHUMAN; PIGMENTATION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RABBIT; SPHINCTER PUPILLAE MUSCLE; TRIGEMINAL NERVE;

ALBINISM; ANIMALS; BOTULINUM TOXIN TYPE A; ELECTRIC STIMULATION; IRIS; ISOMETRIC CONTRACTION; MALE; NERVOUS SYSTEM PHYSIOLOGY; NEUROMUSCULAR AGENTS; PIGMENTATION; PRESYNAPTIC TERMINALS; PUPIL; RABBITS;

EID: 0034603438     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(99)00197-5     Document Type: Article

References (18)

1. Scott A.B., Rosenbaum A., Collins C. Pharmacological weakening of extra-ocular muscles. Invest Ophthalmol Vis Sci. 12:1973;924-927.
2. Osako M., Keltner M.D. Botulinum toxin (Oculinum) in ophthalmology. Surv Ophthalmol. 36:1991;28-46.
3. Kelly R.B., Beutsch J.W., Carlson S.S., Wagner J.A. Biochemistry of neurotransmitter release. Ann Rev Neurosci. 2:1979;399-446.
4. Stanley E.F., Drachman D.B. Botulinum toxin blocks quantal but not non-quantal release of Ach at the neuromuscular junction. Brain Res. 261:1983;172-175.
5. Kern R. Die adrenergischen Receptoren der intraouläen Muskeln der Menschen. Albrecht v Graefes Arch Klin Exp Ophthalmol. 180:1970;231-248.
6. Kupfer C. Selective block on synaptic transmission in ciliary ganglion by type A botulinum toxin in rabbits. Proc Soc Exp Biol Med. 99:1958;474-476.
7. Levy Y., Kremer I., Shavit S., Korczyn A.D. The pupillary effects of retrobulbar injection of botulinum toxin A (Oculinum) in albino rats. Invest Ophthalmol Vis Sci. 32:1991;122-125.
8. Corridan P., Nightingale S., Mashoudi N., Williams A.C. Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol. 74:1990;309-310.
9. Scott A.B. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 79:1981;735-770.
10. Ueda N., Muramatsu I., Sakakibara Y., Fujiwara M. Noncholinergic, nonadrenergic contraction and substance P in rabbit iris sphincter muscle. Jpn J Pharmacol. 31:1981;1071-1079.
11. Wahlestedt C., Bynke G., Beding B., Leithner P.V., Hakanson R. Neurogenic mechanisms in control of the rabbit iris sphincter muscle. Eur J Pharmacol. 117:1985;303-309.
12. Montecucco C., Schiavo G. Structure and function of tetanus and botulinum neurotoxins. Quart Rev Biophys. 28:1995;423-472.
13. Bill A., Stjernschantz J., Mandahl A., Brodin E., Nilsson G. Substance P. release on trigeminal nerve stimulation, effect in the eye Acta Physiol Scand. 106:1979;371-373.
14. Ueda N., Muramatsu I., Fujiwara M. Prostaglandins enhance trigeminal substance P-ergic responses in the rabbit iris sphincter muscles. Brain Res. 337:1985;347-351.
15. Ishikawa H., Yoshitomi T., Harada Y., Katori M., Ishikawa S. The presence of two sites of action of endothelins in the isolated rabbit iris sphincter and dilator muscles. Curr Eye Res. 12:1993;1049-1055.
16. Salazar M., Shimada K., Patil P.N. Iris pigmentation and atropine mydriasis. J Pharmacol Exp Ther. 197:1976;79-88.
17. Ishikawa H., Miller D.D., Patil P.N. Comparison of post-junctional α-adrenoceptors in iris dilator muscle of humans, and albino and pigmented rabbit. Naunyn-Schmiedebergs Arch Pharmacol. 354:1996;765-772.
18. Miller R.N. Disorder of pupillary function, accommodation and lacrimation. Miller R.N. Walsh and Hoyt's clinical neuro-ophthalmology. 1985;469-556 Williams & Wilkins, Baltimore.